GeneDx Holdings (WGS) Cash from Operations (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Cash from Operations data on file, last reported at 32408000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 32408000.0, down 418.29% year-over-year; the trailing twelve-month figure through Mar 2026 was 9311000.0 (down 389.79% YoY), and the FY2025 annual result was 33279000.0, up 216.78% from the prior year.
• Cash from Operations fell to 32408000.0 in Q1 2026 per WGS's latest filing, from 3090000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 15767000.0 in Q3 2025 and troughed at 88362000.0 in Q3 2022.
• A 5-year average of 30995705.88 and a median of 29858000.0 in 2023 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations jumped 458.75% in 2025, then plunged 418.29% in 2026.
• A 5-year view of Cash from Operations shows it stood at 64654000.0 in 2022, then jumped by 53.82% to 29858000.0 in 2023, then soared by 89.34% to 3183000.0 in 2024, then increased by 2.92% to 3090000.0 in 2025, then slumped by 948.8% to 32408000.0 in 2026.
• Business Quant data shows WGS's Cash from Operations at 32408000.0 in Q1 2026, 3090000.0 in Q4 2025, and 15767000.0 in Q3 2025.